Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.
- NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_assertion description "[This study investigated the therapeutic potential of a BRAF(V600E)-selective inhibitor, PLX4032 (RG7204), for thyroid cancer by examining its effects on the MAP kinase signaling and proliferation of 10 thyroid cancer cell lines with wild-type BRAF or BRAF(T1799A) mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.
- NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_assertion evidence source_evidence_literature NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.
- NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_assertion SIO_000772 21185263 NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.
- NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_assertion wasDerivedFrom befree-20150227 NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.
- NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_assertion wasGeneratedBy ECO_0000203 NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP890083.RAF3Ny0yQTraU5Ng4cAtJloqb420XhWkU9HKxDGsYgRJQ130_provenance.